Back
Citius Pharmaceuticals Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
CTXR
Citius Pharmaceuticals
Last Price:
0.13
Seasonality Move:
21.66%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight buying pressure.
Citius Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.27 | Sell |
| 20-day SMA: | 0.33 | Sell |
| 50-day SMA: | 0.4 | Sell |
| 200-day SMA: | 0.64 | Sell |
| 8-day EMA: | 0.24 | Sell |
| 20-day EMA: | 0.31 | Sell |
| 50-day EMA: | 0.4 | Sell |
| 200-day EMA: | 0.61 | Sell |
Citius Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 28.66 | Sell |
| Chaikin Money Flow: | -468685 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.26 - 0.42) | Sell |
| Bollinger Bands (100): | (0.36 - 0.76) | Sell |
Citius Pharmaceuticals Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Pharmaceuticals Stock
Is Citius Pharmaceuticals Stock a Buy?
- Citius Pharmaceuticals share price is 0.17 while CTXR 8-day simple moving average is 0.27, which is a Sell signal.
- The stock price of CTXR is 0.17 while Citius Pharmaceuticals 20-day SMA is 0.33, which makes it a Sell.
- Citius Pharmaceuticals 50-day simple moving average is 0.40 while CTXR share price is 0.17, making it a Sell technically.
- CTXR stock price is 0.17 and Citius Pharmaceuticals 200-day simple moving average is 0.64, creating a Sell signal.
CTXR Technical Analysis vs Fundamental Analysis
Sell
23
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy or a Sell?
-
Citius Pharmaceuticals stock is rated a Sell
The current Citius Pharmaceuticals [CTXR] share price is $0.17. The Score for CTXR is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Citius Pharmaceuticals Stock Info
Market Cap:
29.84M
Price in USD:
0.17
Share Volume:
4.55M
Citius Pharmaceuticals 52-Week Range
52-Week High:
1.07
52-Week Low:
0.15
Sell
23
Citius Pharmaceuticals (CTXR)
is a Sell
Citius Pharmaceuticals Share Price Forecast
-
What is the Citius Pharmaceuticals stock price today?
The Citius Pharmaceuticals stock price is 0.17 USD today. -
Will CTXR stock go up or go down?
Citius Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Citius Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Pharmaceuticals is overvalued.
Is Citius Pharmaceuticals Stock a Buy?
- Citius Pharmaceuticals share price is 0.17 while CTXR 8-day exponential moving average is 0.24, which is a Sell signal.
- The stock price of CTXR is 0.17 while Citius Pharmaceuticals 20-day EMA is 0.31, which makes it a Sell.
- Citius Pharmaceuticals 50-day exponential moving average is 0.40 while CTXR share price is 0.17, making it a Sell technically.
- CTXR stock price is 0.17 and Citius Pharmaceuticals 200-day simple moving average is 0.61, creating a Sell signal.
Fundamental Analysis of Citius Pharmaceuticals
Is Citius Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.23 per share.
Technical Analysis of Citius Pharmaceuticals
Should I short Citius Pharmaceuticals stock?
- CTXR Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Citius Pharmaceuticals is a Sell
- Citius Pharmaceuticals Relative Strength Index (RSI) is 28.66, which suggest Citius Pharmaceuticals is oversold
- The Bollinger Bands (25) for Citius Pharmaceuticals is (0.26 - 0.42), which suggest Citius Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Citius Pharmaceuticals is (0.36 - 0.76), which suggest Citius Pharmaceuticals is a Sell
* Citius Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.